Fig. 6
From: RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
Validation of the RMW signature using the GSE21257 dataset and OS tissue detected by qPCR analysis. A Risk score and survival status and heatmap of the RMW model in OS. B PCA of the high/low-risk groups. C Kaplan–Meier survival curve. D ROC curve analysis of the risk model for OS. E Survival analysis of OS patients with differential expression of CSTF2, ADAR and WTAP. F Survival analysis of OS patients with high/low risk and the ROC analysis of the risk model. G The relationship between risk genes and clinical characteristics